PPP1R18

PPP1R18 (phostensin) is a PP1 regulatory subunit that functions at the interface of actin dynamics, integrin signaling, and endocytic trafficking. It directly binds PP1 and targets the phosphatase to the F-actin cytoskeleton, where its C-terminal actin-binding motif (residues 129–155) together with N-terminal residues 35–51 confer pointed-end capping activity that slows actin filament elongation and depolymerization (PMID:17374523, PMID:19622346, PMID:23443105). In T cells, PPP1R18 is a component of the MIT (MRL–integrin–talin) complex and sustains integrin activation by mediating Rap1 dephosphorylation to preserve Rap1 membrane localization; CRISPR deletion causes lymphocytosis and impaired T-cell homing in vivo (PMID:35766979). PPP1R18 also associates with EHD1/EHD4 at endocytic vesicles through a distinct motif (residues 51–80) to regulate transferrin endocytic recycling, and in osteoclasts its PP1-binding-domain-dependent activity controls podosome actin ring formation and bone resorption (PMID:32800345, PMID:39776131, PMID:29158294).

1. 2007 High

   Establishing the founding identity of PPP1R18: it was unknown how PP1 is recruited to the cortical actin cytoskeleton, and this work showed phostensin directly binds PP1 and targets the holoenzyme to F-actin at the cell periphery, defining it as an actin-directed PP1 regulatory subunit.

   Evidence Yeast two-hybrid, co-immunoprecipitation, GST pull-down, and immunofluorescence in MDCK cells

   PMID:17374523

   Open questions at the time

   • No substrates of the phostensin–PP1 complex identified
   • Mechanism by which phostensin distinguishes cortical actin from other pools not determined
   • Physiological consequence of PP1 targeting to actin unknown
2. 2009 High

   Resolving how phostensin affects actin filament behavior: reconstitution showed it caps pointed ends and inhibits both elongation and depolymerization there, establishing it as a pointed-end capping protein — a rare activity among mammalian actin regulators.

   Evidence In vitro actin dynamics assays with gelsolin-actin seeds and fluorescent single-filament imaging

   PMID:19622346

   Open questions at the time

   • Whether pointed-end capping depends on PP1 association not tested
   • In vivo relevance of pointed-end capping not demonstrated
   • Structural basis of capping unknown
3. 2012 High

   Mapping the molecular architecture underlying pointed-end specificity: the C-terminal actin-binding motif (residues 129–155) was separated from N-terminal residues 35–51 required for pointed-end capping, and intramolecular folding was shown to sterically prevent side-binding and direct the protein to pointed ends.

   Evidence Co-sedimentation, single-filament binding, and truncation/domain analysis in vitro

   PMID:23443105

   Open questions at the time

   • Atomic-resolution structure of the intramolecular fold not solved
   • Regulation of the autoinhibitory fold (e.g. by phosphorylation) not explored
   • Whether PP1 binding alters actin interaction not addressed
4. 2014 Medium

   Identifying an extended isoform (phostensin-β, 613 aa) expanded the gene's coding repertoire and confirmed it retains PP1 and actin binding, raising the question of isoform-specific functions.

   Evidence Immunoprecipitation/shotgun proteomics and 5'-RACE in multiple cell lines

   PMID:24434620

   Open questions at the time

   • Functional distinction between short and long isoforms not established
   • Tissue-specific expression pattern of phostensin-β not characterized
   • Not independently confirmed by other groups
5. 2018 High

   Demonstrating a physiological role in bone biology: PPP1R18 was shown to localize to the nucleus and actin ring in osteoclasts and to inhibit osteoclast differentiation, actin ring formation, and bone resorption in a PP1-binding-domain-dependent manner, connecting the phosphatase-targeting function to a tissue-level phenotype.

   Evidence Co-IP with active Src, immunofluorescence, overexpression/knockdown with PP1-binding-domain mutant rescue, bone resorption assay in osteoclasts

   PMID:29158294

   Open questions at the time

   • Substrates dephosphorylated by the PPP1R18–PP1 complex in osteoclasts not identified
   • Whether Src phosphorylation of PPP1R18 regulates its activity not tested
   • In vivo bone phenotype in knockout animals not reported
6. 2020 Medium

   Revealing a second cellular function beyond actin regulation: phostensin associates with EHD1/EHD4 at endocytic vesicles and its overexpression attenuates transferrin endocytic trafficking, linking PPP1R18 to the endosomal recycling pathway.

   Evidence Co-IP/shotgun proteomics, GST pull-down, immunofluorescence, transferrin trafficking assay

   PMID:32800345

   Open questions at the time

   • Binding site on phostensin mediating EHD interaction not mapped
   • Whether PP1 activity is required for the endocytic function unknown
   • Physiological consequence of attenuated recycling not explored in vivo
7. 2022 High

   Establishing PPP1R18 as a critical regulator of integrin activation in T cells: it was identified as a component of the MIT complex where it dephosphorylates Rap1 to maintain Rap1 activity and membrane localization, with CRISPR knockout causing defective integrin activation, lymphocytosis, and impaired T-cell tissue homing in vivo.

   Evidence Tandem affinity proteomics, CRISPR/Cas9 KO in Jurkat cells and mice, integrin activation assays, flow cytometry, adoptive-transfer colitis model

   PMID:35766979

   Open questions at the time

   • Which specific PP1 catalytic subunit isoform operates within the MIT complex not defined
   • Whether Rap1 is a direct or indirect substrate of the PPP1R18–PP1 complex not biochemically resolved
   • Contribution of actin-capping versus Rap1-dephosphorylation activity to T-cell phenotype not dissected
8. 2025 Medium

   Defining the molecular determinants of the endocytic function: a novel EHD-binding motif (residues 51–80) was mapped, and its mutation abolished both EHD binding and the ability to attenuate transferrin recycling, establishing this motif as functionally essential and separable from the actin- and PP1-binding domains.

   Evidence GST pull-down, far-western blotting, site-directed mutagenesis, transferrin trafficking assay

   PMID:39776131

   Open questions at the time

   • Whether endocytic and actin-capping functions operate simultaneously or in separate pools not tested
   • Structural basis of the EHD-binding motif interaction not solved
   • In vivo physiological consequence of disrupting the EHD-binding motif unknown

• A unified model explaining how PPP1R18 coordinates its multiple interaction surfaces — PP1 binding, pointed-end capping, EHD association, and MIT complex participation — within a single polypeptide, and how these functions are regulated by post-translational modification or isoform expression, remains to be established.
• No high-resolution structure of full-length phostensin exists
• Phosphorylation-dependent regulation of domain switching not characterized
• Relative physiological importance of each function in different cell types not systematically compared